Information  X 
Enter a valid email address

Quantum Exponential (QBIT)

  Print   

Monday 01 November, 2021

Quantum Exponential

Website Address

RNS Number : 9594Q
Quantum Exponential Group PLC
01 November 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART,   DIRECTLY   OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

 

1 November 2021

Quantum Exponential Group Plc

 (the 'Company' or 'Quantum Exponential')

 

Website Address

 

Quantum Exponential Group Plc, a company focused solely on investment opportunities in quantum technology and the wider quantum computing sector, is pleased to confirm that its website with further information for investors can be found at www.quantumexp.co.uk  

**ENDS**

For further information please visit www.quantumexp.co.uk or contact:

Martin Schwedler, Chief Executive Officer                                                         c/o  +44 (0)207 236 1177

Novum Securities  (AQSE Corporate Adviser)

David Coffman / Lucy Bowden           +44 (0)20 7399 9400

Oberon Capital (Broker)                                                                                            +44 (0)20 3179 5344

Mike Seabrook, Chris Crawford, Robert Hayward

St Brides Partners Limited (Financial PR)

Catherine Leftley / Isabelle Morris                                                                             +44 (0)207 236 1177

 

About Quantum Exponential Group Plc

 

Quantum Exponential is a first of its kind, Aquis Stock Exchange listed, investment company focused on opportunities in quantum technology and the wider quantum computing sector, with a highly capable advisory board made up of industry advisors, entrepreneurs, and technology investment professionals with broad access to quantum opportunities and markets. Quantum Exponential's investment strategy is to assemble a portfolio of minority investments in early-stage global quantum technology companies, primarily in NATO allied countries, offering institutional and private investors access to revolutionising technologies and industries in the realms of artificial intelligence, manufacturing and healthcare.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXFLFLELALLIIL

a d v e r t i s e m e n t